Phillips-Medisize Named Winner of 2019 Pharmapack Innovation Award Best Innovation in Drug Delivery

HUDSON, Wis.–(BUSINESS WIRE)–Phillips-Medisize,
a Molex company, has been named 2019 Pharmapack Award winner for Best
Innovation in Drug Delivery with its third-generation Connected Health
Platform (CHP).


Phillips-Medisize created a unified information-sharing and analytics
platform that enables pharmaceutical companies to connect medication and
diagnostic information across their therapy areas on a commercial scale.
The novel cloud-based CHP provides a customizable, scalable medical
device data system (MDDS) for pharmaceutical companies and drug delivery
device developers. The CHP provides customers with a strong
technological foundation and complements Phillips-Medisize’s end-to-end
services which span front-end innovation, early stage development,
manufacturing development, clinical supply through commercial
manufacturing, and post-launch services.

“We are honored to be recognized with this award,” said Matt Jennings,
CEO and President, Phillips-Medisize. “Phillips-Medisize was at the
forefront of connected health solutions with the first FDA approval of a
drug-device connected system, BetaConnect. We have taken the experiences
gained in regulatory submission, field support, market surveillance,
data security and analytics, and patient support from the
first-in-market launch and applied them to our latest release, our
enterprise-scale, cloud hosted, medical device data system (MDDS)
Connected Health Platform. This innovation will allow our customers, the
pharmaceutical, diagnostic and device innovators, to rapidly and
securely manage the data generated as patients use their products.
Through accelerated configuration of a proven MDDS and related
components, our customers can now get compliant systems up and running
in months, saving significant time and cost as compared to custom or
unproven developments. We believe that the Pharmapack Innovation award
reinforces our market leading position.”

Pharmapack attendees have the opportunity to see the CHP and other
Phillips-Medisize solutions at Stand A78 or in the Innovation Gallery
(Stand G10) at the Paris Expo, Porte de Versailles – Hall 7.2, in Paris,
France. Phillips-Medisize will also showcase its CHP and other new
developments in connected health and connected drug delivery devices at
HIMSS19 booth #1559, February 11-15, in Orlando, Florida.

About Phillips-Medisize:

Phillips-Medisize, a Molex company, is an end-to-end provider of
innovation, development, and manufacturing solutions to the
pharmaceutical, diagnostics, and medical device market segments. Backed
by the combined global resources of Molex and its parent company Koch
Industries, Phillips-Medisize’s core advantage is the knowledge of its
people to integrate design, molding, electronics, and automation,
providing innovative, high-quality manufacturing solutions. For more
information, please visit www.phillipsmedisize.com
or www.molex.com.

Contacts

Heather Ditzler
Phone +1 715-377-7261
[email protected]

Christina
Johnson
Phone +1 715-748-8928
[email protected]

Paula
Kasper (Europe)
Phone +41448383933
[email protected]

error: Content is protected !!